Trichodermamide A and aspergillazine A, two cytotoxic modified dipeptides from a marine-derived fungus Spicaria elegans

Arch Pharm Res. 2005 Sep;28(9):1042-6. doi: 10.1007/BF02977399.

Abstract

Two known modified dipeptides, trichodermamide A (1) and aspergillazine A (2), were isolated from an ethyl acetate extract of the metabolite of a marine-derived fungus Spicaria elegans, and were found to have a weak cytotoxic effect on three cancer cell lines P388, A-549, and HL-60 agreed. To our knowledge, this is the first report on the isolation of compounds 1 and 2 from the fungus Spicaria elegans and their cytotoxic effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / isolation & purification*
  • Dipeptides / chemistry
  • Dipeptides / isolation & purification*
  • Dipeptides / pharmacology
  • Fungi / chemistry*
  • HL-60 Cells
  • Humans
  • Mice
  • Water Microbiology

Substances

  • Antineoplastic Agents
  • Dipeptides
  • aspergillazine A
  • trichodermamide A